OASIS Trials
The trial program testing oral semaglutide for weight management — the evidence base behind semaglutide weight-loss pills.
OASIS is to the semaglutide pill what STEP is to the pen: the program testing high-dose oral semaglutide for weight management. Its studies showed daily oral dosing producing double-digit average weight loss over roughly 64 weeks — in the same neighborhood as the weekly injection — establishing that the needle isn't what makes semaglutide work.
The practical caveats are the oral formulation's own: absorption depends on the empty-stomach routine, and results assume the ritual is kept. When our pages cite the pill's 64-week study of 307 adults averaging 14% (~33 lb), that figure belongs to this evidence family; OASIS is the name to search when you want the journal version of the pill's case.
This glossary entry is general information, not medical advice, and is written to be consistent with FDA prescribing information and primary trial publications as of its last review. Always consult a licensed healthcare provider for personal medical decisions.
Questions about OASIS Trials? Ask a doctor free.
A licensed doctor can apply this to your health history in a free telehealth consultation — booking takes about two minutes, with programs from $149/month. You're only charged after approval.
Book an Appointment